San Francisco biotech startup Preventive, backed by Sam Altman and Brian Armstrong, is reigniting global debate over embryo gene editing. Co-founded by CRISPR scientist Lucas Harrington, the company seeks to test whether genetic diseases can be prevented before birth, strictly for research, not reproduction, raising profound ethical, scientific, and societal questions about the future of humanity.